Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | AHCY | P23526 | 1/20 | 0.49 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.48 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9371177 | 0.93 | BCHE (0.52) | BCHEAHCYHSP90B1RXFP1 | |
| SCHEMBL9587865 | 0.85 | ADORA1 (0.43) | — | |
| SCHEMBL9588221 | 0.85 | ADORA1 (0.43) | — | |
| SCHEMBL6243153 | 0.85 | BCHE (0.55) | BCHEAHCYHSP90B1 | |
| SCHEMBL21427226 | 0.85 | BCHE (0.55) | BCHEAHCYHSP90B1 | |
| SCHEMBL6534229 | 0.84 | POLB (0.58) | AHCYEHMT1 | |
| SCHEMBL5358012 | 0.84 | POLB (0.58) | AHCYEHMT1 | |
| SCHEMBL9586410 | 0.84 | ADORA1 (0.44) | — | |
| SCHEMBL22875469 | 0.82 | HINT1 (0.48) | — | |
| SCHEMBL22875428 | 0.82 | AHCY (0.47) | AHCYEHMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210007999-A1 | NANOPARTICLE COMPOSITIONS | JANUARY THERAPEUTICS, INC. | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210007999-A1 | NANOPARTICLE COMPOSITIONS | PNP, NTPCR, TYMP | BCHE 2333/4885AHCY 292/4885HSP90B1 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.